全文获取类型
收费全文 | 1500篇 |
免费 | 82篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 85篇 |
妇产科学 | 28篇 |
基础医学 | 225篇 |
口腔科学 | 46篇 |
临床医学 | 100篇 |
内科学 | 370篇 |
皮肤病学 | 29篇 |
神经病学 | 52篇 |
特种医学 | 126篇 |
外科学 | 204篇 |
综合类 | 40篇 |
预防医学 | 63篇 |
眼科学 | 15篇 |
药学 | 114篇 |
中国医学 | 5篇 |
肿瘤学 | 82篇 |
出版年
2023年 | 18篇 |
2022年 | 18篇 |
2021年 | 44篇 |
2020年 | 31篇 |
2019年 | 30篇 |
2018年 | 48篇 |
2017年 | 24篇 |
2016年 | 47篇 |
2015年 | 36篇 |
2014年 | 47篇 |
2013年 | 71篇 |
2012年 | 80篇 |
2011年 | 75篇 |
2010年 | 51篇 |
2009年 | 53篇 |
2008年 | 49篇 |
2007年 | 61篇 |
2006年 | 48篇 |
2005年 | 47篇 |
2004年 | 43篇 |
2003年 | 45篇 |
2002年 | 33篇 |
2001年 | 31篇 |
2000年 | 29篇 |
1999年 | 37篇 |
1998年 | 39篇 |
1997年 | 33篇 |
1996年 | 37篇 |
1995年 | 32篇 |
1994年 | 23篇 |
1993年 | 23篇 |
1992年 | 22篇 |
1991年 | 22篇 |
1990年 | 29篇 |
1989年 | 21篇 |
1988年 | 31篇 |
1987年 | 25篇 |
1986年 | 14篇 |
1985年 | 20篇 |
1984年 | 8篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 8篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1973年 | 7篇 |
1971年 | 6篇 |
1969年 | 7篇 |
1967年 | 6篇 |
1965年 | 5篇 |
排序方式: 共有1595条查询结果,搜索用时 0 毫秒
31.
Double ProGlide preclose technique for vascular access closure after leadless pacemaker implantation
Deshmukh Amrish Ghannam Michael Cunnane Ryan Liang Jackson J. 《Journal of interventional cardiac electrophysiology》2022,63(2):341-343
Journal of Interventional Cardiac Electrophysiology - The use of vascular closure devices in patients receiving the Micra leadless pacemaker may shorten time to ambulation, facilitate same-day... 相似文献
32.
Amrish Deshmukh MD John Larson MD Michael Ghannam MD Mohammed Saeed MD Ryan Cunnane MD Hamid Ghanbari MD Rakesh Latchamsetty MD Thomas Crawford MD Krit Jongnarangsin MD Frank Pelosi Jr. MD Aman Chugh MD Hakan Oral MD Fred Morady MD Frank Bogun MD Jackson J. Liang DO 《Journal of cardiovascular electrophysiology》2021,32(12):3173-3178
33.
Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis 总被引:1,自引:0,他引:1
Iron chelation treatment of red blood cells infected with Plasmodium falciparum selectively intervenes with iron-dependent metabolism of malaria parasites and inhibits their development. Highly permeant hydroxamate iron chelator RSFileum2 affects all parasite stages when cultures are continuously exposed to drug, but affects primarily ring stages when assessed for irreversible effects, ie, sustained inhibition remaining after drug removal. On the other hand, the hydrophilic and poorly permeant desferrioxamine (DFO) affects primarily trophozoite/schizont stages when tested either in the continuous mode or irreversible mode. Unlike parasites, mammalian cells subjected to similar drug treatment show complete growth recovery once drugs are removed. Our studies indicate that parasites display a limited capacity to recover from intracellular iron depletion evoked by iron chelators. Based on these findings we provide a working model in which the irreversible effects of RSFs on rings are explained by the absence of pathways for iron acquisition/utilization by early forms of parasites. Trophozoite/schizonts can partially recover from RSFileum2 treatments, but show no DNA synthesis following DFO treatment even after drug removal and iron replenishment by permeant iron carriers. At trophozoite stage, the parasite uses a limited pathway for refurnishing its iron-containing enzymes, thus overcoming iron deprivation caused by permeant RSFileum2, but not by DFO because this latter drug is not easily removable from parasites. Their DNA synthesis is blocked by the hydroxamate iron chelators probably by affecting synthesis of ribonucleotide reductase (RNRase). Presumably in parasites, prolonged repression of the enzyme leads also to irreversible loss of activity. The action profiles of RSFileum2 and DFO presented in this study have implications for improved chemotherapeutic performance by combined drug treatment and future drug design based on specific intervention at parasite DNA synthesis. 相似文献
34.
Tejaswini M. Deshmukh Rachita R. Shah Yogesh K. Gurav Vidya A. Arankalle 《Journal of medical virology》2013,85(5):828-832
To investigate the specific immunoglobulin (Ig) G subclass responses in patients with hepatitis E virus (HEV) infection, an open reading frame 2 (ORF2) protein based enzyme‐linked immunosorbant assay was used to measure antibody levels in sera obtained at different phases of infection. Sera were collected at 2–31 days and at 6 months after the onset of symptoms corresponding to the acute (n = 48, 100% IgM‐positive) and convalescent (n = 17/48, 53% IgM‐positive) phases of infection, respectively. IgM‐negative sera from 61 individuals infected at least ≥6 months ago (prior exposure) were also tested. IgG1, IgG2, IgG3, and IgG4 antibodies were detected in 100%, 6%, 56%, and 4% of acute phase sera, respectively, and in 100%, 0%, 0%, and 65% of convalescent phase sera, respectively. IgG1 antibody levels were significantly higher than those of the other detectable subclasses of IgG in the acute and convalescent sera (P < 0.05). The IgG3 antibodies in six acute phase patients were replaced by IgG4 antibodies in the convalescent phase of infection. Patients with prior exposure to HEV had low total IgG antibody titers and decreased IgG1 seropositivity compared with those in the acute and convalescent phases. IgG1 was the only major subclass of antibody to be detected in all the three phases of infection. Other than IgG1 antibodies, the subclass antibody response was restricted to IgG3 and IgG4 antibodies in the acute and convalescent phases of infection, respectively. J. Med. Virol. 85:828–832, 2013. © 2013 Wiley Periodicals, Inc. 相似文献
35.
Srivastava Shriyansh Bagang Newly Yadav Shubham Rajput Sakshi Sharma Divya Dahiya Ashish Bhardwaj Loveinder Deshmukh Khalid Joshi Jagdish Chandra Singh Gaaminepreet 《Inflammation research》2021,70(7):743-747
Inflammation Research - Isoproterenol (ISO) is widely used agent to study the effects of interventions which could prevent or attenuate the development of myocardial infarction. The sequence of... 相似文献
36.
A. Raji K. Navaneetha Pandiyaraj D. Vasu M. C. Ramkumar R. R. Deshmukh V. Kandavelu 《RSC advances》2020,10(59):35709
This paper investigated the degradation of the pharmaceutical drug Valsartan (VS) using non-equilibrium atmospheric pressure plasma (NEAPP) with various operating conditions. The heterogeneous photocatalyst ZnO nanoparticles (NP''s) were synthesized using a hydrothermal process. The morphology, chemical composition and structure of as-synthesized ZnO NPs were examined by Field Emission Scanning Electron Microscopy (FE-SEM), Fourier Transform Infrared Spectroscopy (FTIR) and X-ray diffraction (XRD) analysis. Then, VS degradation was examined in three subsequent treatment conditions including plasma treatment alone, the combination of plasma with as-prepared ZnO NPs and various environments (air, oxygen and hydrogen peroxide) at fixed plasma operating potential and treatment time. The degradation efficiency of plasma-treated VS by various conditions was observed using UV-visible spectroscopy. Optical Emission Spectrometry (OES) was used to characterize the distribution and emission intensity of various reactive species (OH˙, N2-SPS and O) during the degradation processes which plays a vital role in the degradation of VS. The role of OH˙ and H2O2 during the degradation process was further examined by chemical dosimetry and spectroscopic techniques. Furthermore, pH, conductivity and TOC of the untreated and plasma-treated VS were also investigated. The results on the degradation of VS showed that plasma treatment combined with ZnO NP''s has a significant effect on degradation of molecules of VS than degradation processes carried out by other experimental conditions due to the formation of higher concentrations of various reactive oxygen and nitrogen species during the degradation processes.Degradation of valsartan by plasma combined with various environmental conditions. 相似文献
37.
R.D. Deshmukh D.J. Dhande K.S. Sachdeva A.N. Sreenivas A.M.V. Kumar M. Parmar 《The Indian journal of tuberculosis》2018,65(1):41-47
Background
Multidrug-resistant tuberculosis (MDR-TB) is emerging as a major public health problem globally. Treatment success rates in MDR-TB across the globe are not encouraging as completing MDR-TB treatment successfully is challenging due to high proportion of lost to follow up.Methods
Using qualitative methods and grounded theory approach, in-depth interviews were conducted with MDR-TB patients and treatment providers. The social cognitive framework was explored as a way to guide understanding of the factors affecting treatment adherence among MDR-TB patients.Results
Multiple factors influenced patient's decision to adhere to MDR-TB treatment. Self-motivation, awareness about disease and treatment, counselling support, family support, nutritional support and social support were important drivers for successful treatment. Providers related that motivational counselling, nutritional support, family support and social support encouraged treatment adherence.Conclusion
To improve MDR-TB treatment adherence, a patient-centric approach should be considered at the programmatic level. There is a need to formulate strategy that includes motivational counselling, nutritional supplementation and social support mobilisation for treatment adherence. Participants suggested a Patient Support Group led treatment care model for better adherence and treatment success rates in MDR-TB treatment. 相似文献38.
39.
Efficacy and safety of transulnar coronary angiography and interventions—A single center experience 下载免费PDF全文
Anand R. Deshmukh MD Manu Kaushik MD Ahmed Aboeata MBBCH Jamil Abuzetun MD Tammy L. Burns PHARMD Caroline A. Nubel BS Michael D. White MD FACC Thomas J. Lanspa MD FACC Claire B. Hunter MD FACC Aryan N. Mooss MD FACC Dennis J. Esterbrooks MD FACC 《Catheterization and cardiovascular interventions》2014,83(1):E26-E31
40.
Monica Juneja Devendra Mishra Paul S. S. Russell Sheffali Gulati Vaishali Deshmukh Poma Tudu Rajesh Sagar Donald Silberberg Vinod K. Bhutani Jennifer M. Pinto Maureen Durkin Ravindra M. Pandey Mkc Nair Narendra K. Arora 《Indian pediatrics》2014,51(5):359-365